Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600645 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Vcanbio Cell & Gene Engineering Corp., Ltd. on 6ix
Earlier from Vcanbio Cell & Gene Engineering
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Resolutions of the 3rd Extraordinary Meeting of the 12th Board of Directors
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Progress in Using Temporarily Idle Raised Funds for Cash Management
Follow Vcanbio Cell & Gene Engineering into a list and get an email when it puts out news.
Follow Vcanbio Cell & Gene Engineering